Chlorphenamine yellow sensitive tablets

This product is a compound preparation, each tablet contains: 15 mg of diclofenac sodium and 2.5 mg of chlorpheniramine maleate.

This product is a film-coated tablet, which is light yellow after removing the coating.

Oral administration. 2 tablets at a time, 3 times a day or as directed by your doctor.

There are many case reports of children suffering from hematuria after taking the medicine; followed by stomach discomfort and burning sensation; in addition, there are also adverse reactions such as headache, dizziness, drowsiness, rash, palpitations, chest tightness, and sore throat.

1. It is contraindicated for those who are allergic to diclofenac sodium, chlorpheniramine maleate and artificial bezoar. 2. It is contraindicated for newborns or premature infants. 3. It is contraindicated for those with impaired liver and kidney function.

Precautions for children: Not suitable for newborns or premature infants; Use with caution in children. Precautions for pregnancy and lactation: Not suitable for use. Precautions for the elderly: Not clear yet.

1. When taken with aspirin or other salicylic acid drugs, the efficacy does not increase, but the incidence of gastrointestinal adverse reactions and bleeding tendency increases. 2. This product can reduce the effects of insulin and other hypoglycemic drugs, resulting in increased blood sugar; 3. Aspirin can reduce the bioavailability of this product; 4. This product can enhance the effects of amantadine, anticholinergic drugs, phenothiazines and antisympathomimetic drugs; 5. When this product is taken with tricyclic antidepressants, it can enhance the efficacy of the latter.

Keep sealed.

50s

24 months

Guangxi Shengmin Pharmaceutical Co., Ltd.

• Founded in:

  2004-08-19

• Address:

  No. 23, Jingyi Road, Pingtouling Industrial Park, Hepu County, Beihai City

• Tax NO.:

  91450521765818154J

• Registered Funds:

  28.9 million yuan

• Email:

  Log in to view